References
- Saxena SK, Kumar S, Ansari S, et al. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective. J Med Virol. 2021. DOI:10.1002/jmv.27524.
- Ferre VM, Peiffer-Smadja N, Visseaux B, et al. Omicron SARS-CoV-2 variant: what we know and what we don't. Anaesth Crit Care Pain Med. 2022;41:100998. DOI:10.1016/j.accpm.2021.100998.
- WHO. Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern 2021. Available from: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern.
- PONGO. PANGO Lineages:Summary of BA.1 data. Available from: https://cov-lineages.org/global_report_BA.1.html.
- Wang L, Cheng G. Sequence analysis of the emerging SARS-CoV-2 Variant Omicron in South Africa. J Med Virol. 2021. DOI:10.1002/jmv.27516.
- Chen J, Wang R, Gilby NB, et al. Omicron (B.1.1.529): infectivity, vaccine breakthrough, and antibody resistance. J Chem Inf Model. 2022. DOI:10.1021/acs.jcim.1c01451.
- Liu L, Iketani S, Guo Y, et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature. 2021. DOI:10.1038/s41586-021-04388-0.
- Zhang L, Li Q, Liang Z, et al. The significant immune escape of pseudotyped SARS-CoV-2 variant omicron. Emerg Microbes Infect. 2022;11:1–5. DOI:10.1080/22221751.2021.2017757.
- Tan Z, Chen Z, Yu A, et al. The first two imported cases of SARS-CoV-2 Omicron variant — Tianjin municipality. China CDC Weekly; 2021. DOI:10.46234/ccdcw2021.266.